SAB Biotherapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $10.0M | $-2.7M | $12.7M | $1.3M |
| FY2021 | $2.0M | $-9.0M | $10.9M | $2.3M |
| FY2022 | $-23.5M | $-25.6M | $2.2M | $2.7M |
| FY2023 | $-25.1M | $-25.3M | $197.2K | $2.4M |
| FY2024 | $-34.3M | $-34.6M | $337.3K | $2.9M |
| FY2025 | $-44.8M | $-45.7M | $933.2K | $5.2M |